CoChat

Androgens May Mediate a Relative Preservation of IGF-I Levels in Overweight and Obese Women Despite Reduced Growth Hormone Secretion

Open access
Utz, A. L., Yamamoto, A., Sluss, P., Breu, J., Miller, K. K. · 2008 · The Journal of Clinical Endocrinology & Metabolism
Cited by 37

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

CONTEXT: Obesity is characterized by reduced GH secretion, but data regarding IGF-I levels and their determinants are conflicting. OBJECTIVES: The objectives were to determine whether IGF-I levels are reduced and to investigate determinants of GH and IGF-I in healthy overweight and obese women. DESIGN: A cross-sectional study was performed. SETTING: The study was conducted at a General Clinical Research Center. STUDY PARTICIPANTS: Thirty-four healthy women without pituitary/hypothalamic disease participated, including 11 lean [body mass index (BMI) <25 kg/m(2)], 12 overweight (BMI > or =25 kg/m(2) and <30 kg/m(2)), and 11 obese (BMI > or =30 kg/m(2)) women of comparable age (overall mean age, 30.7 +/- 7.8 yr). INTERVENTION: There was no intervention. MAIN OUTCOME MEASURES: The main outcome measures were frequent sampling (every 10 min for 24 h) for GH, peak GH after GHRH-arginine stimulation, IGF-I, IGF binding protein-3, estrone, estradiol, testosterone, free testosterone, SHBG, homeostasis model assessment of insulin resistance, and abdominal fat. RESULTS: Mean 24-h GH and peak stimulated GH were lower in overweight than lean women and lowest in obese women. Mean IGF-I levels trended lower in obese, but not overweight, compared with lean women. Free testosterone was positively associated with IGF-I (R = 0.36, P = 0.04) but not with GH measures. Visceral fat was the only determinant of mean 24-h GH (R(2) = 0.66, P < 0.0001) and of peak stimulated GH (R(2) = 0.63, P < 0.0001), and mean 24-h GH accounted for 39% of the variability of IGF-I (P = 0.0002), with an additional 28% (P < 0.0001) attributable to free testosterone levels. CONCLUSIONS: Despite a linear decrease in GH secretion and peak stimulated GH levels with increasing BMI in healthy overweight and obese women, IGF-I levels were not commensurately reduced. Androgens may contribute to this relative preservation of IGF-I secretion in overweight and obese women despite reduced GH secretion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2008-0930

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 42

  1. Copeland, 1990, The relationship between insulin-like growth factor-I, adiposity, and aging, Metabolism, 39, 584, 10.1016/0026-0495(90)90022-5 · DOI · Paper page
  2. Rasmussen, 1995, Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects., J Clin Endocrinol Metab, 80, 1407
  3. Yamamoto, 1993, Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults., Endocr J, 40, 41, 10.1507/endocrj.40.41 · DOI
  4. Marin, 1993, Low concentrations of insulin-like growth factor-I in abdominal obesity., Int J Obes Relat Metab Disord, 17, 83
  5. Rasmussen, 2007, Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism., Obesity (Silver Spring), 15, 879, 10.1038/oby.2007.607 · DOI
  6. Gram, 2006, Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women., Int J Obes (Lond), 30, 1623, 10.1038/sj.ijo.0803324 · DOI
  7. Maccario, 1999, Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients., Int J Obes Relat Metab Disord, 23, 612, 10.1038/sj.ijo.0800889 · DOI
  8. Caufriez, 1984, Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects., Clin Endocrinol (Oxf), 20, 65, 10.1111/j.1365-2265.1984.tb00060.x · DOI
  9. Hochberg, 1992, The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa., Metabolism, 41, 106, 10.1016/0026-0495(92)90198-J · DOI · Paper page
  10. Nam, 1997, Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone., Int J Obes Relat Metab Disord, 21, 355, 10.1038/sj.ijo.0800412 · DOI · Paper page
  11. Clasey, 2001, Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors., J Clin Endocrinol Metab, 86, 3845, 10.1210/jcem.86.8.7731 · doi:10.1210/jcem.86.8.7731 · Paper page
  12. Vahl, 1996, Abdominal adiposity and physical fitness are major determinants of the age-associated decline in stimulated GH secretion in healthy adults., J Clin Endocrinol Metab, 81, 2209
  13. Rasmussen, 1994, The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone., Metabolism, 43, 315, 10.1016/0026-0495(94)90099-X · DOI
  14. Giusti, 1989, The effect of long-term pulsatile GnRH administration on the 24-hour integrated concentration of GH in hypogonadotropic hypogonadic patients., Acta Endocrinol (Copenh), 120, 724, 10.1530/acta.0.1200724 · DOI
  15. Liu, 1987, Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism., J Clin Endocrinol Metab, 64, 651, 10.1210/jcem-64-4-651 · DOI · Paper page
  16. Giustina, 1997, Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone., J Clin Endocrinol Metab, 82, 1210
  17. Keenan, 1993, Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty., J Clin Endocrinol Metab, 76, 996
  18. Loche, 1997, The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids., J Clin Endocrinol Metab, 82, 861
  19. Veldhuis, 2005, Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy., Eur J Endocrinol, 153, 577, 10.1530/eje.1.02001 · DOI · Paper page
  20. Gibney, 2005, Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men, Am J Physiol Endocrinol Metab, 289, E266, 10.1152/ajpendo.00483.2004 · DOI · Paper page
  21. Landin-Wilhelmsen, 2004, Insulin-like growth factor I levels in healthy adults, Horm Res, 62, 8
  22. Parkinson, 2001, The relationship between serum GH and serum IGF-I in acromegaly is gender-specific., J Clin Endocrinol Metab, 86, 5240, 10.1210/jcem.86.11.8006 · DOI
  23. Burman, 1997, Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women., J Clin Endocrinol Metab, 82, 550
  24. Utz, 2008, Growth hormone deficiency by GHRH/arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women., J Clin Endocrinol Metab, 93, 2507, 10.1210/jc.2008-0169 · DOI
  25. Koutkia, 2004, Growth hormone-releasing hormone in HIV-infected men with lipodystrophy., JAMA, 292, 210, 10.1001/jama.292.2.210 · DOI · Paper page
  26. Eden Engstrom, 2006, Effects of gastric bypass on the GH/IGF-I axis in severe obesity—and a comparison with GH deficiency., Eur J Endocrinol, 154, 53, 10.1530/eje.1.02069 · DOI
  27. Valera Mora, 2007, Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery., Obesity (Silver Spring), 15, 2012, 10.1038/oby.2007.240 · DOI
  28. De Marinis, 2004, Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition., J Clin Endocrinol Metab, 89, 174, 10.1210/jc.2002-021308 · DOI · Paper page
  29. Lukanova, 2002, Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)., Cancer Causes Control, 13, 509, 10.1023/A:1016392129279 · DOI
  30. Bednarek-Tupikowska, 2008, The correlations between endogenous dehydroepiandrosterone sulfate and some atherosclerosis risk factors in premenopausal women, Med Sci Monit, 14, CR37
  31. Maccario, 1999, Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women., Clin Endocrinol (Oxf), 50, 595, 10.1046/j.1365-2265.1999.00692.x · DOI
  32. Ovesen, 1998, Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women., J Clin Endocrinol Metab, 83, 1662, 10.1210/jcem.83.5.4761 · doi:10.1210/jcem.83.5.4761 · Paper page
  33. Bellantoni, 1996, Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study., J Clin Endocrinol Metab, 81, 2848
  34. Friend, 1996, Both oral and transdermal estrogen increase growth hormone release in postmenopausal women—a clinical research center study., J Clin Endocrinol Metab, 81, 2250
  35. Baxter, 1988, Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex., J Clin Endocrinol Metab, 67, 265, 10.1210/jcem-67-2-265 · DOI · Paper page
  36. Lamson, 1991, Insulin-like growth factor binding proteins: structural and molecular relationships., Growth Factors, 5, 19, 10.3109/08977199109000268 · doi:10.3109/08977199109000268
  37. Le Roith, 2001, The somatomedin hypothesis: 2001., Endocr Rev, 22, 53, 10.1210/edrv.22.1.0419 · DOI · Paper page
  38. Roelen, 1997, Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein., J Clin Endocrinol Metab, 82, 760, 10.1210/jcem.82.3.3836 · DOI
  39. Buijs, 2003, Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism., Am J Clin Nutr, 77, 544, 10.1093/ajcn/77.3.544 · DOI
  40. Pijl, 2001, Altered neuroregulation of GH secretion in viscerally obese premenopausal women., J Clin Endocrinol Metab, 86, 5509, 10.1210/jcem.86.11.8061 · doi:10.1210/jcem.86.11.8061 · Paper page
  41. Weltman, 2003, Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults., Metabolism, 52, 73, 10.1053/meta.2003.50007 · DOI
  42. Miller, 2005, Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk., J Clin Endocrinol Metab, 90, 768, 10.1210/jc.2004-0894 · DOI · Paper page

Cited by

See all 37

Metadata

Authors
Utz, A. L., Yamamoto, A., Sluss, P., Breu, J., & Miller, K. K.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2008-10-01
Volume
93
Issue
10
Pages
4033-4040
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2095967997
Cited by
37
References
10
FWCI
1.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.